Capivasertib (breast cancer) – 2nd Addendum to Project A24-105

Report documents

1. Addendum

   Capivasertib (breast cancer) – 2nd Addendum to Project A24-105

   published on

   03.04.2025

   Document type

   PDF-Dokument, 378 kB, DE, PDF

   DOI-Link

   https://doi.org/10.60584/G25-06

   Download file : Addendum (PDF-Dokument, 378 kB, DE, PDF)

Additional information

Project details

Project no.

G25-06

Commission

Commission awarded on 11.02.2025 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Health Economics

Topic

Cancer

Note

If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.

DOI

https://doi.org/10.60584/G25-06

Connected Projects

1. Dossier assessment

   Capivasertib (breast cancer) – Benefit assessment according to §35a Social Code Book V

   Project no.

   A24-105

   Last updated

   03.04.2025

   Status: Commission completed